U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Vermillion, Inc. (VRML)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.29+0.05 (+4.03%)
At close: 4:00PM EDT
People also watch
ROSGPSDVBASIAPRIVCYT
Full screen
Previous Close1.24
Open1.22
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.20 - 1.29
52 Week Range0.76 - 2.85
Volume10,559
Avg. Volume38,756
Market Cap72.45M
Beta1.82
PE Ratio (TTM)-6.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Is It Too Late To Buy Vermillion Inc (VRML)?
    Simply Wall St.3 days ago

    Is It Too Late To Buy Vermillion Inc (VRML)?

    Vermillion Inc (NASDAQ:VRML), a healthcare equipment and services company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on theRead More...

  • Capital Cube4 days ago

    ETFs with exposure to Vermillion, Inc. : September 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Vermillion, Inc. Here are 5 ETFs with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
    Capital Cube5 days ago

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017

    Categories: Yahoo FinanceGet free summary analysis Vermillion, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Vermillion, Inc. – OraSure Technologies, Inc., Quest Diagnostics Incorporated, Akers Biosciences, Inc., Chembio Diagnostics, Inc., Foundation Medicine, Inc., Biocept, Inc., Myriad Genetics, Inc. and Quidel Corporation (OSUR-US, DGX-US, AKER-US, ... Read more (Read more...)